Cargando…
Anti-inflammatory and biologic drugs for atopic dermatitis: a therapeutic approach in children and adolescents
Atopic dermatitis (AD) is a chronic inflammatory disease with a heterogeneous pathogenesis correlated with dysregulation of the immune system and a prevalence of the T2-mediated immune pathway. Recent understanding of the pathogenesis of AD has allowed the development of new drugs targeting differen...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466416/ https://www.ncbi.nlm.nih.gov/pubmed/37654660 http://dx.doi.org/10.3389/fmed.2023.1214963 |
_version_ | 1785098878699175936 |
---|---|
author | Caffarelli, Carlo Giannetti, Arianna Giannì, Giuliana Ricci, Giampaolo |
author_facet | Caffarelli, Carlo Giannetti, Arianna Giannì, Giuliana Ricci, Giampaolo |
author_sort | Caffarelli, Carlo |
collection | PubMed |
description | Atopic dermatitis (AD) is a chronic inflammatory disease with a heterogeneous pathogenesis correlated with dysregulation of the immune system and a prevalence of the T2-mediated immune pathway. Recent understanding of the pathogenesis of AD has allowed the development of new drugs targeting different mechanisms and cytokines that have changed the treatment approach. The aim of this review is to update knowledge on the standard of care and recent advancements in the control of skin inflammation. In light of recent guidelines, we report on the clinical efficacy of novel treatments, with special attention to situations where biologics and small molecules are involved. |
format | Online Article Text |
id | pubmed-10466416 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104664162023-08-31 Anti-inflammatory and biologic drugs for atopic dermatitis: a therapeutic approach in children and adolescents Caffarelli, Carlo Giannetti, Arianna Giannì, Giuliana Ricci, Giampaolo Front Med (Lausanne) Medicine Atopic dermatitis (AD) is a chronic inflammatory disease with a heterogeneous pathogenesis correlated with dysregulation of the immune system and a prevalence of the T2-mediated immune pathway. Recent understanding of the pathogenesis of AD has allowed the development of new drugs targeting different mechanisms and cytokines that have changed the treatment approach. The aim of this review is to update knowledge on the standard of care and recent advancements in the control of skin inflammation. In light of recent guidelines, we report on the clinical efficacy of novel treatments, with special attention to situations where biologics and small molecules are involved. Frontiers Media S.A. 2023-08-16 /pmc/articles/PMC10466416/ /pubmed/37654660 http://dx.doi.org/10.3389/fmed.2023.1214963 Text en Copyright © 2023 Caffarelli, Giannetti, Giannì and Ricci. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Caffarelli, Carlo Giannetti, Arianna Giannì, Giuliana Ricci, Giampaolo Anti-inflammatory and biologic drugs for atopic dermatitis: a therapeutic approach in children and adolescents |
title | Anti-inflammatory and biologic drugs for atopic dermatitis: a therapeutic approach in children and adolescents |
title_full | Anti-inflammatory and biologic drugs for atopic dermatitis: a therapeutic approach in children and adolescents |
title_fullStr | Anti-inflammatory and biologic drugs for atopic dermatitis: a therapeutic approach in children and adolescents |
title_full_unstemmed | Anti-inflammatory and biologic drugs for atopic dermatitis: a therapeutic approach in children and adolescents |
title_short | Anti-inflammatory and biologic drugs for atopic dermatitis: a therapeutic approach in children and adolescents |
title_sort | anti-inflammatory and biologic drugs for atopic dermatitis: a therapeutic approach in children and adolescents |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466416/ https://www.ncbi.nlm.nih.gov/pubmed/37654660 http://dx.doi.org/10.3389/fmed.2023.1214963 |
work_keys_str_mv | AT caffarellicarlo antiinflammatoryandbiologicdrugsforatopicdermatitisatherapeuticapproachinchildrenandadolescents AT giannettiarianna antiinflammatoryandbiologicdrugsforatopicdermatitisatherapeuticapproachinchildrenandadolescents AT giannigiuliana antiinflammatoryandbiologicdrugsforatopicdermatitisatherapeuticapproachinchildrenandadolescents AT riccigiampaolo antiinflammatoryandbiologicdrugsforatopicdermatitisatherapeuticapproachinchildrenandadolescents |